Profil
Martine J.
van Vugt is currently Director at Hollandbio, Non-Executive Director at Merus NV starting in 2025, Chief Strategy Officer & Executive Vice President at Genmab A since 2023, and Member of the Supervisory Board at Flindr Therapeutics BV.
Former positions include Independent Director at Scandion Oncology A from 2022 to 2024 and Independent Member of the Supervisory Board at TME Pharma NV from 2021 to 2023.
Education includes a doctorate from the University of Utrecht and a graduate degree from Wageningen University.
Aktive Positionen von Martine van Vugt
| Unternehmen | Position | Beginn |
|---|---|---|
| GENMAB A/S | Corporate Officer/Principal | 29.03.2023 |
| MERUS N.V. | Direktor/Vorstandsmitglied | 12.12.2025 |
Immagene BV
Immagene BV Pharmaceuticals: MajorHealth Technology Develops novel therapies for cancer patients | Direktor/Vorstandsmitglied | - |
Hollandbio | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Martine van Vugt
| Unternehmen | Position | Ende |
|---|---|---|
| SCANDION ONCOLOGY A/S | Direktor/Vorstandsmitglied | 01.05.2024 |
| TME PHARMA N.V. | Direktor/Vorstandsmitglied | 29.06.2023 |
Ausbildung von Martine van Vugt
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Genmab A/S
Genmab A/S BiotechnologyHealth Technology Operates as a biotechnology company for improving the lives of people with cancer and serious diseases through antibody medicines | Health Technology |
University of Utrecht
University of Utrecht Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merus NV
Merus NV BiotechnologyHealth Technology Discovers and develops therapeutics for cancer treatment | Health Technology |
Wageningen University
Wageningen University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TME Pharma NV
TME Pharma NV BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company | Health Technology |
Scandion Oncology A/S
Scandion Oncology A/S Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for chemotherapy resistance mechanisms | Health Technology |
Hollandbio | |
Immagene BV
Immagene BV Pharmaceuticals: MajorHealth Technology Develops novel therapies for cancer patients | Health Technology |
















